Heterogeneity in access and toxicity management of commercially available BCMA-directed CAR-T and Bispecific T-cell engager therapy among the international myeloma community Meeting Abstract
| Authors: | Hassan, H.; Samur, M. K.; Cohen, A. D.; Moreau, P.; Otero, P. R.; Kumar, S. K.; Mateos, M. V.; Avigan, D.; Sperling, A. S.; Nadeem, O.; Hudecek, M.; de Larrea, C. F.; Martínez-López, J.; Themeli, M.; Yong, K.; Berdeja, J. G.; Chari, A.; Sonneveld, P.; Gay, F.; Krishnan, A.; Usmani, S. Z.; Anderson, K. C.; Jagannath, S.; Einsele, H.; Munshi, N. C.; Midha, S. |
| Abstract Title: | Heterogeneity in access and toxicity management of commercially available BCMA-directed CAR-T and Bispecific T-cell engager therapy among the international myeloma community |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 7248 |
| Language: | English |
| ACCESSION: | WOS:001159900808002 |
| DOI: | 10.1182/blood-2023-184710 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
